Ultragenyx to Host Conference Call for Second Quarter 2026 Financial Results and Corporate Update
Ultragenyx (NASDAQ: RARE) will host a conference call at 5:00 p.m. ET on Tuesday, August 4, 2026, to review its financial results and corporate update for the quarter ended June 30, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ultragenyx (NASDAQ: RARE) will host a conference call at 5:00 p.m. ET on Tuesday, August 4, 2026, to review its financial results and corporate update for the quarter ended June 30, 2026. A live and replay webcast will be accessible via the company’s investor relations website, with the replay available for three months.
Details
News Market Reaction – RARE
On Jul 29, the first trading day after this news, RARE closed 3.77% below the previous close. Our momentum scanner recorded 9 alerts for this stock that day.
Data tracked by StockTitan Argus for the Jul 29 session.
Key Figures
- Announcement date
- July 28, 2026
- Article publication date
- Conference call date
- August 4, 2026
- Second-quarter 2026 results call
- Conference call time
- 5:00 p.m. ET
- August 4, 2026
- Quarter end
- June 30, 2026
- Quarter covered by the upcoming financial results
- Replay availability
- three months
- Conference call replay
Previous Conferences,earnings date Reports
-
Scheduled first-quarter 2026 results call and corporate update for May 5.
-
Scheduled fourth-quarter and full-year 2025 results call for February 12.
-
Scheduled third-quarter 2025 results call and corporate update for November 4.
-
Scheduled second-quarter 2025 results call for August 5.
-
Scheduled first-quarter 2025 results call and corporate update for May 6.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NOVATO, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Tuesday, August 4, 2026, to discuss its financial results and corporate update for the quarter ending June 30, 2026.
The live and replayed webcast of the call will be available through the company’s website at https://ir.ultragenyx.com/events-presentations. The replay of the call will be available for three months.
About Ultragenyx Pharmaceutical Inc.
Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.
The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.
For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.
Contact Ultragenyx
Investors
Joshua Higa
ir@ultragenyx.com
Media
Jess Rowlands
media@ultragenyx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.